Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | ARG2 | P78540 | 1/20 | 0.40 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | IDO1 | P14902 | 2/20 | 0.37 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | AGXT | P21549 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1157684 | 0.76 | GPR52 (0.42) | LTA4HALDH1A1IDO1LOXL2TDP1 | |
| SCHEMBL6632695 | 0.76 | CYP1A2 (0.44) | TP53TSHRALDH1A1LOXL2KDM4E | |
| SCHEMBL625599 | 0.76 | MAOB (0.61) | MAOBTP53LTA4HTSHRCA1 | |
| SCHEMBL2702507 | 0.76 | MAOB (0.48) | MAOBTP53LTA4HTSHRCA1 | |
| SCHEMBL1781025 | 0.76 | MAOB (0.61) | MAOBTP53LTA4HTSHRCA1 | |
| SCHEMBL4073089 | 0.76 | ALDH1A1 (0.63) | MAOBTP53LTA4HTSHRCA1 | |
| SCHEMBL2701270 | 0.75 | MAOB (0.46) | MAOBTP53TSHRCA1CA2 | |
| SCHEMBL20739984 | 0.75 | MAOB (0.46) | MAOBTP53LTA4HTSHRCA1 | |
| SCHEMBL6629615 | 0.74 | CHRNB2 (0.48) | ALDH1A1TDP1 | |
| SCHEMBL1066575 | 0.73 | TSHR (0.50) | MAOBTSHRCA1CA2ARG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 794 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3688124-B1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-10-25 | — | — | EP | claimed |
| WO-2023177250-A1 | NOVEL HETEROCYCLIC INHIBITOR FOR HISTONE DEACETYLASE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 숙명여자대학교산학협력단 | 2023-09-21 | — | — | WO | claimed |
| CN-116367565-A | Quasi two-dimensional perovskite nanocrystalline modified three-dimensional perovskite solar cell | 河北工业大学 | 2023-06-30 | — | — | CN | claimed |
| CN-111278797-B | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium | 株式会社力森诺科 | 2023-06-16 | — | — | CN | claimed |
| WO-2023043197-A1 | NOVEL CANNABIDIOL DERIVATIVE, METHOD FOR PREPARING SAME, AND COMPOSITION FOR COGNITIVE FUNCTION IMPROVEMENT COMPRISING SAME | 강원대학교 산학협력단 | 2023-03-23 | — | — | WO | claimed |
| CN-111032625-B | Fluorinated ether compound, lubricant for magnetic recording medium, and magnetic recording medium | 昭和电工株式会社 | 2022-12-09 | — | — | CN | claimed |
| EP-3688124-A1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | ExxonMobil Chemical Patents Inc. (US) | 2020-08-05 | — | — | EP | claimed |
| US-10711216-B2 | Ester compounds, lubricating oil compositions containing same and processes for making same | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-07-14 | — | — | US | claimed |
| CN-111386331-A | Ester compound, lubricating oil composition containing same, and method for producing same | 埃克森美孚化学专利公司 | 2020-07-07 | — | — | CN | claimed |
| CN-106986807-B | 5- amino -4- nitro-pyrrole ketone compound and preparation method and application | 云南大学 | 2019-10-11 | — | — | CN | claimed |
| EP-0175525-A1 | 7-[2-(Dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones | SMITHKLINE BEECHAM CORPORATION (US) | 1986-03-26 | — | — | EP | claimed |
| EP-0174811-A2 | 7-(2-aminoethyl)-1,3-Benzthia- or oxa- zol-2(3H) -ones | SMITHKLINE BECKMAN CORPORATION (US) | 1986-03-19 | — | — | EP | claimed |
| EP-0167288-A2 | 4-(2-(N,N-disubstituted-amino)ethyl]isatins | SMITHKLINE BEECHAM CORPORATION (US) | 1986-01-08 | — | — | EP | claimed |
| US-4554287-A | Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones | SMITHKLINE BECKMAN CORPORATION (US) | 1985-11-19 | — | — | US | claimed |
| US-4544652-A | α-Hydroxyethylphosphinates, and their use as fungicides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-10-01 | — | — | US | claimed |
| US-4435392-A | 2,5-Benzodiazocine derivatives and salts thereof, as well as pharmaceutical agent comprising as effective component at least one of the derivatives and salts | SANWA KAGAKU KENKYUSHO CO. LTD. (JP) | 1984-03-06 | — | — | US | claimed |
| EP-0093010-A2 | Alpha-hydroxyethylphosphinates, and their production and use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-11-02 | — | — | EP | claimed |
| EP-0089743-A1 | Novel 2,5-benzodiazocines and salts thereof having pharmaceutical activity | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 1983-09-28 | — | — | EP | claimed |
| US-4016263-A | BACTERICIDES | BOEHRINGER INGELHEIM GMBH (DT) | 1977-04-05 | — | — | US | claimed |
| US-3971804-A | ACARICIDES, FUNGICIDES, INSECTICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-07-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10711216-B2 | Ester compounds, lubricating oil compositions containing same and processes for making same | ELOVL1, NOTUM, ELOVL5 | MAOB 2292/4885TP53 1828/4885LTA4H 677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.